Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEvolent Health Inc

Evolent Health Inc

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
4.99 USD 0.19 ( 3.96%)
Last update at 2026-11-11T21:13:00Z
VOLUME
1438527
Market Cap
351.66M

Momentum Score

…

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.77
Low
5.00
High
52 Week Price Range
2.10
Low
12.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Evolent Health provides technology-enabled services and clinical operations to health plans and providers to support value-based care, including population health management, analytics and risk-contract administration. Long-term growth may be supported by the secular shift to value-based reimbursement, expansion of risk arrangements and rising demand for analytics-driven care management, and investors may find its recurring-revenue model and scalable platform attractive.

Key risks include exposure to contract performance under risk-sharing arrangements, customer concentration, regulatory and reimbursement changes, and execution and competitive pressure as the company scales.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.80
Dividend Yield
-
Revenue TTM
1876.23M
Revenue Per Share
16.43
Gross Profit TTM
399.88M
Debt / Equity
2.38
ROE
-66.54%
Net Debt
837.84M
ROCE
-31.52%
Diluted EPS TTM
-5.07

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -534.64M -63.04M -202.41M -62.08M -29.80M
Minority interest - - - - 0.00M
Net income -534.51M -61.62M -113.04M -18.70M -30.28M
Selling general administrative 303.87M 263.05M 358.11M 245.75M 219.50M
Gross profit 283.03M 367.35M 460.47M 316.58M 250.41M
Reconciled depreciation 115.85M 118.37M 123.42M 67.19M 60.04M
Ebit -477.17M -38.31M -148.20M -59.84M 30.25M
Ebitda -361.31M 84.85M -24.79M 7.36M 90.28M
Depreciation and amortization 115.85M 123.17M 123.42M 67.19M 60.04M
Non operating income net other - - - 6.00M 13.59M
Operating income -4.43M -40.48M -71.21M -59.84M 30.25M
Other operating expenses 1880.66M 2595.23M 2035.11M 1371.89M 937.09M
Interest expense 57.47M 24.72M 54.20M 15.57M 25.43M
Tax provision -0.13M -1.41M -89.36M -43.38M 0.48M
Interest income 4.19M 5.54M 5.26M 9.63M 0.41M
Net interest income -53.28M -19.18M -48.95M -14.20M -25.02M
Extraordinary items - 0.00M 0.00M -0.46M -7.32M
Income tax expense -0.13M -1.41M -89.36M -43.38M 0.48M
Total revenue 1876.23M 2554.74M 1963.90M 1352.01M 907.96M
Total operating expenses 287.47M 407.84M 531.68M 336.46M 279.54M
Cost of revenue 1593.20M 2187.39M 1503.43M 1035.43M 657.55M
Total other income expense net -530.20M -22.55M -131.19M -2.24M -60.05M
Discontinued operations - - - -0.46M -7.32M
Net income from continuing ops -534.51M -61.62M -113.04M -18.70M -30.28M
Net income applicable to common shares -579.40M -93.45M -142.26M -19.16M -37.60M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1899.24M 2544.41M 2680.31M 1817.29M 1419.46M
Intangible assets 584.94M 680.16M 752.01M 442.78M 279.78M
Other current assets 31.12M 28.94M 44.10M 451.10M 435.30M
Total liab 1484.04M 1543.15M 1612.61M 957.88M 725.83M
Total stockholder equity 415.19M 1001.26M 1067.70M 859.42M 693.63M
Deferred long term liab - - - 4.74M 1.40M
Other current liab 308.94M 418.79M 610.28M 363.39M 330.40M
Common stock 1.18M 1.17M 1.15M 1.01M 0.91M
Capital stock 1.18M 1.17M 1.15M 1.01M 0.91M
Retained earnings -1315.33M -780.82M -719.19M -606.15M -626.78M
Other liab - - - 55.44M 6.93M
Good will 694.48M 1137.32M 1116.54M 722.77M 426.30M
Other assets 19.32M 31.95M 33.01M 32.30M 52.39M
Cash 151.86M 104.20M 192.82M 188.20M 266.28M
Cash and equivalents 151.86M 104.20M 192.82M 188.20M 266.28M
Total current liabilities 385.26M 715.50M 674.24M 433.44M 445.49M
Current deferred revenue 1.20M 2.51M 5.98M 5.76M 11.94M
Net debt 837.84M 609.47M 451.97M 287.92M 14.19M
Short term debt 15.34M 198.18M 9.74M 7.12M 7.07M
Short long term debt - 171.47M - - -
Short long term debt total 989.70M 713.67M 644.80M 476.12M 280.47M
Other stockholder equity 1731.97M 1782.66M 1787.00M 1465.73M 1319.87M
Property plant equipment 85.16M 79.28M 90.18M 87.87M 81.36M
Total current assets 506.37M 607.12M 683.67M 478.05M 523.96M
Long term investments 8.97M 8.59M 4.89M 4.47M 5.46M
Net tangible assets - - - -306.14M -12.45M
Short term investments - 59.30M 13.77M 14.49M 75.69M
Net receivables 323.40M 414.68M 446.75M 254.68M 130.60M
Long term debt 970.54M 490.52M 597.05M 412.99M 215.68M
Inventory - - 0.00M -415.93M -308.22M
Accounts payable 59.78M 96.03M 48.25M 57.17M 96.08M
Accumulated other comprehensive income -2.62M -1.75M -1.26M -1.18M -0.36M
Common stock total equity - - - 1.01M 0.91M
Retained earnings total equity - - - -606.15M -626.78M
Treasury stock - - - - -21.12M
Non currrent assets other 19.32M 31.95M 33.01M 32.30M 12.98M
Non current assets total 1392.86M 1937.29M 1996.63M 1339.24M 895.50M
Capital lease obligations 19.16M 51.69M 47.75M 63.13M 64.79M
Long term debt total 970.54M 490.52M 597.05M 412.99M 215.68M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -62.93M -413.95M 36.52M 54.22M
Change to liabilities - - - -16.89M 7.73M
Total cashflows from investing activities -0.23M -62.93M -415.54M -259.12M -15.79M
Net borrowings 65.06M 58.58M 183.29M 219.74M -98.85M
Total cash from financing activities -35.92M -0.56M 281.34M 131.54M -29.55M
Change to operating activities - - - -8.12M -14.38M
Net income -579.40M -61.62M -113.04M -19.16M -37.60M
Change in cash 14.49M -44.96M 8.30M -139.78M -6.64M
Begin period cash flow 163.50M 223.46M 215.16M 354.94M 361.58M
End period cash flow 177.99M 178.50M 223.46M 215.16M 354.94M
Total cash from operating activities 38.84M 18.77M 142.58M -11.55M 38.75M
Issuance of capital stock 0.00M 0.00M 168.00M - -
Depreciation 122.64M 125.61M 123.42M 67.19M 60.04M
Other cashflows from investing activities 34.85M -30.72M -387.67M -295.64M -70.00M
Dividends paid 11.13M 20.09M 18.79M -14.88M -1.30M
Change to inventory - - -10.75M - -14.12M
Change to account receivables 73.70M 32.06M -164.69M -102.98M -5.78M
Sale purchase of stock -40.00M -16.62M -15.29M -10.43M 11.99M
Other cashflows from financing activities -49.86M -42.52M 116.84M 146.43M 70.60M
Change to netincome - - - -26.91M 17.00M
Capital expenditures 34.09M 24.89M 28.75M 38.36M 24.98M
Cash flows other operating - - - -18.09M -26.47M
Cash and cash equivalents changes - - - -139.13M -6.59M
Change in working capital -57.38M -116.56M 21.89M -104.44M -13.64M
Stock based compensation 39.74M 39.75M 40.50M 33.98M 16.71M
Other non cash items 516.23M 34.40M 101.09M 10.53M 13.77M
Free cash flow 4.75M -6.13M 113.84M -49.91M 13.76M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EVH
Evolent Health Inc		 0.19
3.96%		 4.99 - 16.29 0.19 0.79 0.62 88.49
VEEV
Veeva Systems Inc Class A		 -0.78
0.26%		 304.77 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited		 -2.18
1.51%		 141.82 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock		 -1.11
1.38%		 79.43 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc		 -0.11
1.88%		 5.73 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Evolent Health Inc

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

1812 N. Moore Street, Arlington, VA, United States, 22209

571 389 6000

https://www.evolent.com

4200

Name Title Year Born
Mr. Frank John Williams Co-Founder & Chairman 1966
Mr. Seth Barrie Blackley Co-Founder, CEO & Director 1979
Mr. John Paul Johnson Chief Financial Officer 1984
Mr. Steve Tutewohl FSA, MAAA Chief Operating Officer 1973
Mr. Aammaad Shams Chief Accounting Officer & Controller 1984
Mr. Jonathan David Weinberg J.D. Chief Legal Officer, Gen. Counsel & Sec. 1968
Mr. Dan McCarthy CEO of New Century Health & Pres NA
Mr. Seth R. Frank VP of Investor Relations NA
Ms. Jessica Somers Sr. VP of Corp. Devel. NA
Ms. Kali Beyah Chief People & Brand Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

MAL
CAD 38.85
+13.53%
SOIL
CAD 8.39
+12.02%
QNC
CAD 1.48
+10.45%
TCL-B
CAD 7.26
+9.01%
CLS
CAD 345.53
+8.41%
GSY
CAD 37.75
-16.04%
BYD
CAD 109.98
-11.99%
ELE
CAD 20.12
-11.95%
LAC
CAD 2.39
-11.15%
CFW
CAD 6.51
-10.82%

Equity Sectors*

  • Basic Materials

    -1.75%

  • Communication Services

    +0.20%

  • Consumer Cyclical

    +0.18%

  • Consumer Defensive

    +0.06%

  • Energy

    +1.65%

  • Financial Services

    +0.10%

  • Healthcare

    +1.25%

  • Industrials

    +1.60%

  • Real Estate

    -0.29%

  • Technology

    +2.72%

  • Utilities

    +0.12%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…